The Seattle-based firm is working with Oregon Health & Science University researcher Lisa Coussens on a tool for studying the innate immune system in oncology.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.
Researchers performed metagenomic sequencing on sea samples from two ocean voyages to uncover double-stranded DNA virus communities at sites around the world.
The Ontario Institute for Cancer Research will work with prostate cancer data while Dana Farber Cancer Institute's pilot has yet to be decided.
The partners will work on pilot projects that use novel analytical approaches to explore oncology molecular and imaging data.
The company said it plans to launch a clinical trial to validate its Immray PanCan-d blood test in both Europe and the US.
The partners will try to validate the Immray PanCan-d array-based test, which looks at proteins associated with the immune response to pancreatic cancer.
The organizations will create an integrated omics laboratory to investigate disease biomarkers for new drug therapies.
NEW YORK (GenomeWeb) – In a study appearing online today in Nature, an international team outlined findings from an effort to genomically characterize gibbons, a group of small apes that d
Originally published on July 10.
NEW YORK (GenomeWeb) – Participation in Novartis' biomarker based signal-finding trials, known as the Signature Program, is progressing at an encouraging pace, according to researchers involved in the effort.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.